News
SIGA
2.740
-5.19%
-0.150
SIGA Technologies Earnings Call Highlights Growth and Risks
TipRanks · 9h ago
SIGA Technologies, Inc. Reports $15 Million Procurement Contract and Financial Results for Three and Nine Months Ended September 30, 2026
NASDAQ · 5d ago
SIGA Technologies GAAP EPS of -$0.04, revenue of $1.3M
Seeking Alpha · 5d ago
SIGA Technologies Q3 EPS $(0.04) Up From $(0.09) YoY, Sales $1.317M Down From $2.620M YoY
Benzinga · 5d ago
Press Release: SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
Dow Jones · 5d ago
Press Release: SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
Dow Jones · 5d ago
Weekly Report: what happened at SIGA last week (1102-1106)?
Weekly Report · 6d ago
Weekly Report: what happened at SIGA last week (1026-1030)?
Weekly Report · 11/02 09:15
SIGA Wins Canadian Defence Contract Worth Up To $15M For Smallpox Antiviral; Stock Up
NASDAQ · 10/28 12:30
Siga Technologies awarded $15M oral Tpoxx contract from PSPC
TipRanks · 10/28 11:42
SIGA secures $15M contract from Canadian Department of National Defence
Seeking Alpha · 10/28 11:39
SIGA Technologies Receives ~$15M Contract From Public Services And Procurement Canada To Procure Oral TPOXX
Benzinga · 10/28 11:32
Weekly Report: what happened at SIGA last week (1019-1023)?
Weekly Report · 10/26 09:15
Weekly Report: what happened at SIGA last week (1012-1016)?
Weekly Report · 10/19 09:15
Weekly Report: what happened at SIGA last week (1005-1009)?
Weekly Report · 10/12 09:16
Weekly Report: what happened at SIGA last week (0928-1002)?
Weekly Report · 10/05 09:16
How To YieldBoost SIGA To 37.4% Using Options
NASDAQ · 10/01 15:50
Weekly Report: what happened at SIGA last week (0921-0925)?
Weekly Report · 09/28 09:15
Weekly Report: what happened at SIGA last week (0914-0918)?
Weekly Report · 09/21 09:15
Weekly Report: what happened at SIGA last week (0907-0911)?
Weekly Report · 09/14 09:16
More
Webull provides a variety of real-time SIGA stock news. You can receive the latest news about Siga Technologie through multiple platforms. This information may help you make smarter investment decisions.
About SIGA
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company. The Company is focused on the development of medicines to treat and prevent infectious diseases. Its flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the United States and Canada for the treatment of smallpox and authorized in Europe, the United Kingdom, and Japan for the treatment of smallpox, monkeypox (mpox), cowpox, and vaccinia complications. TPOXX specifically inhibits the activity of a protein called VP37, found on the surface of all orthopoxviruses. This prevents the virus from leaving infected cells, slowing the spread of the infection and limiting it to a point where the immune system can clear the virus. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox.